Lead Product(s): HTL0014242
Therapeutic Area: Neurology Product Name: TMP-301
Highest Development Status: Phase I Product Type: Small molecule
Partner/Sponsor/Collaborator: Aditum Bio
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Licensing Agreement November 02, 2020
Tempero Bio will obtain exclusive global rights to a portfolio of potent, orally available metabotropic glutamate receptor 5 NAM modulators, including HTL0014242, which were precision-designed by Sosei Heptares using its GPCR Structure-Based Drug Design (SBDD) platform.